These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27651661)

  • 21. Association of insulin resistance with polycystic ovary syndrome phenotypes and patients' characteristics: a cross-sectional study in Iran.
    Rahmatnezhad L; Moghaddam-Banaem L; Behroozi-Lak T; Shiva A; Rasouli J
    Reprod Biol Endocrinol; 2023 Nov; 21(1):113. PubMed ID: 38001527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
    Ganie MA; Rashid A; Baba MS; Zargar MA; Wani IA; Nisar S; Wani IA; Douhath S; Sriwastawa M; Geer MI; Asrar MM; Kutum R; Hassan S; Khan S; Rafi W; Bhat DA; Showkat W; Sahar T; Choh NA; Khurshid R; Mudassar S; Shah ZA; Shabir I; Sofi SA; Gupta N; Hafeez I; Sreenivas V
    Clin Endocrinol (Oxf); 2023 Dec; 99(6):566-578. PubMed ID: 37656656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Body Mass Index with Anthropometric and Biochemical Parameters Among Polycystic Ovary Syndrome Phenotypes.
    Mehra T; Sharma S; Zahra T; Jangir S; Gupta B
    Indian J Clin Biochem; 2023 Apr; 38(2):231-241. PubMed ID: 37025434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.
    Krentowska A; Łebkowska A; Jacewicz-Święcka M; Hryniewicka J; Leśniewska M; Adamska A; Kowalska I
    Endocrine; 2021 May; 72(2):400-410. PubMed ID: 33442790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.
    Krentowska A; Kowalska I
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3464. PubMed ID: 33988288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
    J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
    Pustotina O; Myers SH; Unfer V; Rasulova I
    Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obese and Non-obese Polycystic Ovarian Syndrome: Comparison of Clinical, Metabolic, Hormonal Parameters, and their Differential Response to Clomiphene.
    Sachdeva G; Gainder S; Suri V; Sachdeva N; Chopra S
    Indian J Endocrinol Metab; 2019; 23(2):257-262. PubMed ID: 31161114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there differences in basal thrombophilias and C-reactive protein between women with or without PCOS?
    Sánchez-Ferrer ML; Prieto-Sánchez MT; Corbalán-Biyang S; Mendiola J; Adoamnei E; Hernández-Peñalver AI; Carmona-Barnosi A; Salido-Fiérrez EJ; Torres-Cantero AM
    Reprod Biomed Online; 2019 Jun; 38(6):1018-1026. PubMed ID: 31023609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis on endocrine and metabolic features of different phenotypes of polycystic ovary syndrome patients.
    Li F; Yao L; Wu H; Cao S
    Pak J Pharm Sci; 2016 Sep; 29(5 Suppl):1735-1738. PubMed ID: 28476694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-metabolic risk in Rotterdam clinical phenotypes of PCOS.
    Mitra S; Saharia GK; Jena SK
    Ann Endocrinol (Paris); 2024 Feb; 85(1):44-47. PubMed ID: 37328054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
    Fertil Steril; 2009 Aug; 92(2):626-34. PubMed ID: 18706545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
    Abruzzese GA; Gamez J; Belli SH; Levalle OA; Mormandi E; Otero P; Graffigna MN; Cerrone GE; Motta AB
    Gynecol Endocrinol; 2020 Dec; 36(12):1057-1061. PubMed ID: 32496833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.